US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anti-Pandemic Concept

1,480.02

-0.00620.00%

Number of Gainers:7

Number of Losers:13

Number of Flat:- -

PE:- -

High:1,493.87

Open:1,479.95

Low:1,472.49

Close:1,480.06

Loading ...

BRIEF-UK's MHRA Says mRESVIA RSV Vaccine Approved To Protect Patients Aged 60 And Over

New Treatments Give Hope to Patients With One of the Deadliest Cancers -- WSJ

Bernstein Remains a Hold on Pfizer (PFE)

3 Reasons ABBV is Risky and 1 Stock to Buy Instead

Wall Street's Greatest Dividend Stock Just Made History Again -- and 99.9% of Investors Have Never Heard of This Small-Cap Company

Medical Devices & Supplies - Diversified Stocks Q4 Teardown: Stryker (NYSE:SYK) Vs The Rest

Bear of the Day: Krispy Kreme (DNUT)

APT Satellite Holdings to Announce Annual Results and Dividend Consideration

Barclays Remains a Buy on Vir Biotechnology (VIR)

FBI Links $1.5 Billion Bybit Hack to North Korea’s Lazarus Group

Analysts Offer Insights on Healthcare Companies: Novavax (NVAX) and Ramsay Health Care (OtherRMSYF)

Abbott (ABT) Stock Moves -0.07%: What You Should Know

Novavax to Participate in Upcoming March Investor Conferences

GeoVax Response to WHO's Third Declaration of Mpox as a Public Health Emergency of International Concern

Invivyd (NasdaqGM:IVVD) Surges 198% After Positive Results From VYD2311 COVID-19 Trial

Simply Wall St.

Moderna Shares Fall After Reports of HHS Review of Bird Flu Vaccine Contract -- WSJ

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4568/news?page=14"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1480.0494,"timestamp":1741632763309,"preClose":1480.0557,"halted":0,"volume":80521613,"delay":0,"changeRate":-0.000004,"change":-0.006226,"pbRate":4.037358,"amount":4829943048.840689,"amplitude":0.01444,"prevYearClose":1274.8187,"fiveDayClose":1475.2046,"twentyDayClose":1354.9427,"turnoverRate":0.005206,"marketCap":1219956363827.5,"floatMarketCap":1198581485341,"peRate":31.999995},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1493.8654,"amplitude":0.01444,"preClose":1480.0557,"low":1472.4934,"pbRate":"4.037358","latestPrice":1480.0193,"volume":80521257,"delay":0,"open":1479.9548,"prevYearClose":1274.8187,"prevWeekClose":1480.0557,"prevMonthClose":1463.5875,"prevQuarterClose":1274.8187,"fiveDayClose":1475.2046,"twentyDayClose":1354.9427,"sixtyDayClose":1302.6017,"secType":"PLATE","market":"US","turnoverRate":0.005206,"peRate":31.999995,"marketCap":1219956363827.5,"floatMarketCap":1198581485341,"timestamp":1741632762668,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":7,"down":13,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:16,pageCount:14,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514901344","title":"BRIEF-UK's MHRA Says mRESVIA RSV Vaccine Approved To Protect Patients Aged 60 And Over","url":"https://stock-news.laohu8.com/highlight/detail?id=2514901344","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514901344?lang=en_us&edition=fundamental","pubTime":"2025-02-28 18:37","pubTimestamp":1740739049,"startTime":"0","endTime":"0","summary":"BRIEF-UK's MHRA Says mRESVIA RSV Vaccine Approved To Protect Patients Aged 60 And OverFeb 28  - MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY: UK'S MHRA SAYS MRESVIA RSV VACCINE APPROVED TO PROTECT PATIENTS AGED 60 AND OVERUK'S MHRA SAYS MRNA RSV VACCINE TO PROTECT PATIENTS AGED 60 AND OVER AGAINST LOWER RESPIRATORY TRACT DISEASE CAUSED BY RSVSource text: [ID:]Further company coverage: MRNA.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nFWN3PJ0VV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4551","BK4533","BK4588","BK4548","BK4585","BK4501","BK4532","BK4534","MRNA","BK4568"],"gpt_icon":1},{"id":"2514344899","title":"New Treatments Give Hope to Patients With One of the Deadliest Cancers -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2514344899","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514344899?lang=en_us&edition=fundamental","pubTime":"2025-02-28 18:30","pubTimestamp":1740738600,"startTime":"0","endTime":"0","summary":"By Brianna Abbott | Photographs by Helynn Ospina for WSJ. Pranathi Perati was running out of time to treat her stage-four pancreatic cancer when she found out she would get another shot: a clinical trial testing a new experimental drug.Perati's odds were slim -- only 3% of late-stage pancreatic cancer patients are still alive after five years. And half of all pancreatic cancer patients live for less than a year after their diagnosis. For Perati, the drug, daraxonrasib from Revolution Medicines, has helped keep her alive for 17 months and counting.Pancreatic cancer is one of the toughest cancers to treat. Often caught late, it kills nearly 52,000 people in the U.S. each year, making it the country's third leading cause of cancer death, behind lung and colorectal. Case rates have gradually increased, particularly among younger women, in part because of rising obesity rates.Researchers believe that could change with newer therapies, particularly those that target KRAS. The gene acts as a ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","LU0456855351.SGD","BK4007","BK4533","LU0985481810.HKD","LU1894683348.USD","SG9999011175.SGD","IE00BLSP4452.SGD","LU1057294990.SGD","IE00B19Z3B42.SGD","LU0225771236.USD","PFE","IE0002270589.USD","LU0170899867.USD","LU0321505439.SGD","LU1883839398.USD","BK4599","SG9999003800.SGD","LU0289739699.SGD","LU1066051498.USD","LU0058720904.USD","LU1023059063.AUD","BK4581","SG9999001176.SGD","LU1066053197.SGD","IE00B19Z3581.USD","IE00BBT3K403.USD","SGXZ57979304.SGD","LU0234572021.USD","BK4534","SG9999001176.USD","LU0306806265.USD","SG9999002232.USD","BK4211","LU0225284248.USD","LU0306807586.USD","LU0868494617.USD","LU0122379950.USD","SG9999013999.USD","HOPE","SG9999002224.SGD","LU0321505868.SGD","BK4568","BK4585","BK4588","LU1894683264.USD","IE00BLSP4239.USD","IE000M9KFDE8.USD","BK4592"],"gpt_icon":0},{"id":"2514411973","title":"Bernstein Remains a Hold on Pfizer (PFE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514411973","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514411973?lang=en_us&edition=fundamental","pubTime":"2025-02-28 18:16","pubTimestamp":1740737777,"startTime":"0","endTime":"0","summary":"Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target of $30.00. The company...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bernstein-remains-a-hold-on-pfizer-pfe-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bernstein-remains-a-hold-on-pfizer-pfe-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0234572021.USD","IE00B19Z3B42.SGD","IE0002270589.USD","LU0170899867.USD","LU0321505868.SGD","BK4534","LU1883839398.USD","BK4533","LU0225284248.USD","LU1894683348.USD","LU1057294990.SGD","BK4588","LU0306806265.USD","IE00BBT3K403.USD","LU1023059063.AUD","SG9999013999.USD","IE000M9KFDE8.USD","LU0122379950.USD","LU0321505439.SGD","LU1894683264.USD","SGXZ57979304.SGD","BK4585","LU0456855351.SGD","SG9999001176.SGD","IE00BLSP4239.USD","SG9999002232.USD","SG9999011175.SGD","BK4592","LU0225771236.USD","BK4568","IE00B19Z3581.USD","LU0289739699.SGD","BK4599","LU0868494617.USD","LU0985481810.HKD","BK4007","BK4581","PFE","LU0306807586.USD","SG9999001176.USD","LU1066051498.USD","LU0058720904.USD","SG9999002224.SGD","LU1066053197.SGD","IE00BLSP4452.SGD","SG9999003800.SGD","BK4550"],"gpt_icon":0},{"id":"2514326532","title":"3 Reasons ABBV is Risky and 1 Stock to Buy Instead","url":"https://stock-news.laohu8.com/highlight/detail?id=2514326532","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514326532?lang=en_us&edition=fundamental","pubTime":"2025-02-28 17:07","pubTimestamp":1740733642,"startTime":"0","endTime":"0","summary":"AbbVie trades at $205.51 per share and has stayed right on track with the overall market, gaining 5.2% over the last six months. At the same time, the S&P 500 has returned 5.1%.Is now the time to buy AbbVie, or should you be careful about including it in your portfolio?Get the full stock story straight from our expert analysts, it’s free.We don't have much confidence in AbbVie. Here are three reasons why we avoid ABBV and a stock we'd rather own.Founded in 2013 as a spin-off from Abbott Laboratories , AbbVie  is a biopharmaceutical company that develops and sells prescription medicines focused on areas like immunology , oncology , and neuroscience .AbbVie isn’t a terrible business, but it isn’t one of our picks. That said, the stock currently trades at 16.7× forward price-to-earnings . Beauty is in the eye of the beholder, but we don’t really see a big opportunity at the moment. We're fairly confident there are better stocks to buy right now. Let us point you toward a dominant Aerospac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-reasons-abbv-risky-1-090722642.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0256863902.USD","IE00BSNM7G36.USD","BK4568","ABT","LU0943347566.SGD","LU1093756325.SGD","BK4139","BK4585","SG9999003800.SGD","LU1061106388.HKD","IE00BDGV0183.EUR","LU0266013472.USD","LU1551013425.SGD","LU2347655156.SGD","IE00BVYPNV92.GBP","BK4592","LU1914381329.SGD","BK4566","LU0310800379.SGD","LU0965508806.USD","LU0310799852.SGD","LU0882574055.USD","LU0158827948.USD","LU2468319806.SGD","LU1585245621.USD","SG9999015986.USD","LU1037948541.HKD","LU0689472784.USD","BK4581","LU1093756168.USD","IE00B42XCP33.USD","BK4559","LU0203345920.USD","LU0708994859.HKD","LU0795875086.SGD","LU1291159041.SGD","BK4082","IE00B4R5TH58.HKD","LU0949170772.SGD","IE00BVYPNW00.USD","ABBV","LU2089984988.USD","LU2237443465.HKD","LU1267930573.SGD","LU1721429741.USD","LU1267930490.SGD","SG9999001440.SGD","SG9999002232.USD","LU0211328371.USD"],"gpt_icon":0},{"id":"2514492183","title":"Wall Street's Greatest Dividend Stock Just Made History Again -- and 99.9% of Investors Have Never Heard of This Small-Cap Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2514492183","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514492183?lang=en_us&edition=fundamental","pubTime":"2025-02-28 17:06","pubTimestamp":1740733560,"startTime":"0","endTime":"0","summary":"This virtually unknown company has been paying a continuous dividend for six decades longer than any other U.S. stock.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/02/28/wall-street-greatest-dividend-stock-made-history/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0203345920.USD","LU1196500208.SGD","SG9999001440.SGD","LU0122379950.USD","BK4568","BK4127","IE00B1BXHZ80.USD","JNJ","LU1066051498.USD","LU1868836914.USD","LU2505996509.AUD","SG9999004303.SGD","IE00BFTCPJ56.SGD","LU1988902786.USD","ISBC","IE00B4R5TH58.HKD","LU0175139822.USD","IE00BJT1NW94.SGD","LU1720051017.SGD","LU2112291526.USD","LU0098860793.USD","LU1244550221.USD","BK4534","LU0096364046.USD","LU2237443549.SGD","LU2129689514.USD","IE00B19Z3B42.SGD","LU0971096721.USD","LU2264538146.SGD","LU2237443382.USD","IE000M9KFDE8.USD","LU1363072403.SGD","LU1868837136.USD","BK4592","IE00BBT3K403.USD","LU2271345857.HKD","LU1868836757.USD","LU0289960550.SGD","LU2592432038.USD","LU0006306889.USD","LU1670710661.SGD","LU1023059063.AUD","LU1732799900.SGD","LU1670711123.USD","AAA","LU1116320901.HKD","LU2089283258.USD","BK4533","LU0106261372.USD"],"gpt_icon":1},{"id":"2514323675","title":"Medical Devices & Supplies - Diversified Stocks Q4 Teardown: Stryker (NYSE:SYK) Vs The Rest","url":"https://stock-news.laohu8.com/highlight/detail?id=2514323675","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514323675?lang=en_us&edition=fundamental","pubTime":"2025-02-28 17:04","pubTimestamp":1740733452,"startTime":"0","endTime":"0","summary":"As the craze of earnings season draws to a close, here’s a look back at some of the most exciting  results from Q4. Today, we are looking at medical devices & supplies - diversified stocks, starting with Stryker .The 5 medical devices & supplies - diversified stocks we track reported a strong Q4. As a group, revenues beat analysts’ consensus estimates by 1.8% while next quarter’s revenue guidance was in line.In light of this news, share prices of the companies have held steady. On average, they are relatively unchanged since the latest earnings results.Stryker reported revenues of $6.44 billion, up 10.7% year on year. This print exceeded analysts’ expectations by 1.4%. Overall, it was a strong quarter for the company with an impressive beat of analysts’ organic revenue estimates and a decent beat of analysts’ EPS estimates.“We delivered another year of double-digit organic sales growth while continuing to expand adjusted operating margins and drive adjusted earnings per share growth,” ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/medical-devices-supplies-diversified-stocks-090412604.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2491049909.HKD","LU0528227936.USD","LU0345769631.USD","LU0048584097.USD","LU2237957902.USD","BSX","LU0234572021.USD","BK4585","LU1153585028.USD","BK4082","LU2491050071.SGD","LU1989771016.USD","IE00BJJMRZ35.SGD","LU0187121727.USD","LU0690374961.EUR","BK4568","LU1989772923.USD","LU2265009873.SGD","LU2133065610.SGD","LU0251132253.USD","LU2237957811.SGD","LU1989772840.SGD","GB00B4QBRK32.GBP","LU0310799852.SGD","NYSE","ABT","LU0238689110.USD","LU1023059063.AUD","LU2506951958.HKD","BK4566","GB00B4LPDJ14.GBP","LU0823417737.USD","NEOG","SYK","LU2089984988.USD","BAX","LU0114720955.EUR","BK4592","IE00BJT1NW94.SGD","LU1989764748.USD","LU2098885051.SGD","LU0162691827.USD","BK4504","LU2324357040.USD","LU0122379950.USD","LU2087625088.SGD","LU0353189680.USD","LU0690374615.EUR","LU1691799644.USD","LU2506952170.USD"],"gpt_icon":0},{"id":"2514694341","title":"Bear of the Day: Krispy Kreme (DNUT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514694341","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514694341?lang=en_us&edition=fundamental","pubTime":"2025-02-28 17:00","pubTimestamp":1740733200,"startTime":"0","endTime":"0","summary":"Zacks Rank #5  stock Krispy Kreme  is a Charlotte-based. Globally recognized sweet treat brand, best known for its signature “Original Glazed” doughnut. Krispy Kreme’s company model consists of a fresh doughnut shop network , retail strategic partnerships, and e-commerce and delivery growth. The company operates mainly in the US and Canada; however, its international footprint extends to the UK, Australia, and Mexico. In addition, the company has a diversified sweet treat portfolio that includes entities like Insomnia Cookies. That said, Krispy Kreme’s success mainly depends on its fresh doughnuts segment.Though New Year’s health resolutions are nothing new, a 2025 Ipsos poll found that “Younger Americans are particularly likely to resolve to healthier living – and even if you’ve been keeping up with Gen Z wellness trends, the extent of that enthusiasm is striking.Krispy Kreme, a globally recognized sweet treat brand heavily reliant on its fresh doughnut segment, faces significant chal","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bear-day-krispy-kreme-dnut-090000398.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BNTX","BK4139","BK4568","BK4585","BK4009","HHS","BK4551","BK4209","BK4588","BK4548","DNUT","BK4535","BK4539"],"gpt_icon":0},{"id":"2514489123","title":"APT Satellite Holdings to Announce Annual Results and Dividend Consideration","url":"https://stock-news.laohu8.com/highlight/detail?id=2514489123","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514489123?lang=en_us&edition=fundamental","pubTime":"2025-02-28 16:44","pubTimestamp":1740732282,"startTime":"0","endTime":"0","summary":"APT Satellite Holdings ( ($HK:1045) ) has provided an update. APT Satellite Holdings Limited has announced that its board of directors will meet on...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/apt-satellite-holdings-to-announce-annual-results-and-dividend-consideration?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/apt-satellite-holdings-to-announce-annual-results-and-dividend-consideration?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APT","BK4568","BK4086"],"gpt_icon":0},{"id":"2514531412","title":"Barclays Remains a Buy on Vir Biotechnology (VIR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514531412","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514531412?lang=en_us&edition=fundamental","pubTime":"2025-02-28 16:16","pubTimestamp":1740730596,"startTime":"0","endTime":"0","summary":"In a report released today, Gena Wang from Barclays maintained a Buy rating on Vir Biotechnology (VIR – Research Report), with a price target of $3...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-buy-on-vir-biotechnology-vir?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-buy-on-vir-biotechnology-vir?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4535","VIR","BK4585","BK4568"],"gpt_icon":0},{"id":"2514396433","title":"FBI Links $1.5 Billion Bybit Hack to North Korea’s Lazarus Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2514396433","media":"CoinMarketCap","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514396433?lang=en_us&edition=fundamental","pubTime":"2025-02-28 12:39","pubTimestamp":1740717563,"startTime":"0","endTime":"0","summary":"The Federal Bureau of Investigation  has officially attributed the recent $1.5 billion cyberattack on cryptocurrency exchange Bybit to North Korea’s state-sponsored Lazarus Group. The attack, which occurred on February 21, saw hackers infiltrate one of Bybit’s cold wallets and steal over 41,000 ETH.This breach added to a growing list of high-profile cryptocurrency heists orchestrated by North Korean hacking entities.US Authorities Sound Alarm on North Korea’s Crypto Heists. In a joint Cybersecurity Advisory  issued by the FBI, the Cybersecurity and Infrastructure Security Agency , and the US Treasury Department, authorities warned about the increasing cyber risks posed by North Korea-backed advanced persistent threat  groups.The Lazarus Group, also known by aliases such as APT38, BlueNoroff, and Stardust Chollima, has been conducting cyber theft operations since at least 2020. The entity has been known for systematically targeting cryptocurrency exchanges, decentralized finance  protoc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/67c13dfd0ff87258b89e5f5d/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["BK4086","IE00BHPRN162.USD","CSA","LU0149725797.USD","BK4568","APT"],"gpt_icon":0},{"id":"2514967352","title":"Analysts Offer Insights on Healthcare Companies: Novavax (NVAX) and Ramsay Health Care (OtherRMSYF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514967352","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514967352?lang=en_us&edition=fundamental","pubTime":"2025-02-28 07:40","pubTimestamp":1740699604,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Novavax (NVAX – Research Report) and Ramsay Health...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-novavax-nvax-and-ramsay-health-care-otherrmsyf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-novavax-nvax-and-ramsay-health-care-otherrmsyf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4585","HCSG","BK4139","NVAX","BK4588","BK4547","BK4568"],"gpt_icon":0},{"id":"2514350399","title":"Abbott (ABT) Stock Moves -0.07%: What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2514350399","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514350399?lang=en_us&edition=fundamental","pubTime":"2025-02-28 06:50","pubTimestamp":1740696603,"startTime":"0","endTime":"0","summary":"Abbott  ended the recent trading session at $135.87, demonstrating a -0.07% swing from the preceding day's closing price. This change was narrower than the S&P 500's 1.59% loss on the day. Meanwhile, the Dow experienced a drop of 0.45%, and the technology-dominated Nasdaq saw a decrease of 2.78%.Shares of the maker of infant formula, medical devices and drugs witnessed a gain of 6.34% over the previous month, beating the performance of the Medical sector with its gain of 1.73% and the S&P 500's loss of 2.23%.The upcoming earnings release of Abbott will be of great interest to investors. On that day, Abbott is projected to report earnings of $1.07 per share, which would represent year-over-year growth of 9.18%. Our most recent consensus estimate is calling for quarterly revenue of $10.39 billion, up 4.28% from the year-ago period.Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $5.15 per share and revenue of $44.35 billion, indicating changes of +10.28% and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/abbott-abt-stock-moves-0-225003562.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4566","LU1057294990.SGD","LU2468319806.SGD","LU1023059063.AUD","LU2237957811.SGD","SG9999002232.USD","BK4592","IE00B2B36J28.USD","BK4581","LU0234572021.USD","LU0868494617.USD","LU2133065610.SGD","SG9999004303.SGD","LU2237957902.USD","LU1691799644.USD","IE00BJJMRZ35.SGD","BK4504","LU0170899867.USD","BK4588","SGXZ23171101.USD","LU0266013472.USD","IE0009355771.USD","IE00BJT1NW94.SGD","LU0122379950.USD","IE0002141913.USD","BK4585","BK4568","LU1989763427.SGD","IE00B4R5TH58.HKD","LU2112291526.USD","BK4533","LU1061106388.HKD","LU1914381329.SGD","IE00BFTCPJ56.SGD","BK4082","ABT","LU1721429402.USD","LU1989763690.USD","LU1721429741.USD","LU2089984988.USD","SG9999002224.SGD"],"gpt_icon":0},{"id":"2514835876","title":"Novavax to Participate in Upcoming March Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2514835876","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514835876?lang=en_us&edition=fundamental","pubTime":"2025-02-28 05:05","pubTimestamp":1740690300,"startTime":"0","endTime":"0","summary":"GAITHERSBURG, Md., Feb. 27, 2025 /PRNewswire/ -- Novavax, Inc. , today announced that the management team will participate in the following upcoming investor conferences:. A webcast of the fireside chat and presentation will be available through the Events and Presentations page of the Company's website at ir.novavax.com, with replays available for 30 days after the conferences.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/novavax-participate-upcoming-march-investor-210500594.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novavax-participate-upcoming-march-investor-210500594.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4144","NVAX","BK4561","ET","BK4590","BK4585","BK4568","BK4581","BK4547","BK4588"],"gpt_icon":0},{"id":"2514331728","title":"GeoVax Response to WHO's Third Declaration of Mpox as a Public Health Emergency of International Concern","url":"https://stock-news.laohu8.com/highlight/detail?id=2514331728","media":"NewMediaWire","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514331728?lang=en_us&edition=fundamental","pubTime":"2025-02-28 03:22","pubTimestamp":1740684136,"startTime":"0","endTime":"0","summary":"GeoVax Advancing GEO-MVA Vaccine Candidate to Bolster Global Supply Options. ATLANTA, GA - February 27, 2025  - GeoVax Labs, Inc.  commented on today's statement from The World Health Organization  concerning Mpox. In its statement the WHO reaffirmed the severity of the ongoing Mpox epidemic, issuing its third declaration within six months of Mpox as a Public Health Emergency of International Concern . This follows the initial declaration on August 14, 2024, and the second on November 22, 2024, underscoring the persistent and escalating nature of the outbreak.GEO-MVA, in conjunction with the GeoVax development program of implementing an advanced manufacturing process for MVA vaccines, may offer several key advantages to complement and potentially strengthen the global Mpox response:. Expanded manufacturing capacity at lower cost - The advanced MVA manufacturing process is directed towards establishing a higher yield, increased production capability with lower production costs.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/geovax-response-whos-third-declaration-192216075.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BNTX","R","BK4568","GOVX","GOVXW","BK4548","BK4139","BK4022","BK4585","BK4588","BK4232","BK4551","BK4535"],"gpt_icon":1},{"id":"2514363253","title":"Invivyd (NasdaqGM:IVVD) Surges 198% After Positive Results From VYD2311 COVID-19 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2514363253","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514363253?lang=en_us&edition=fundamental","pubTime":"2025-02-28 03:04","pubTimestamp":1740683057,"startTime":"0","endTime":"0","summary":"Invivyd (NasdaqGM:IVVD) experienced a significant 198% price increase over the past month, likely driven by the release of positive clinical data for its novel monoclonal antibody candidate, VYD2311. The promising results from the Phase 1/2 trial revealed improved safety and enhanced antiviral potency, positioning the company as a potential leader in COVID-19 treatment alternatives. This advancement coincides with a mixed performance in the broader U.S. stock market, where major indices...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ivvd/invivyd/news/invivyd-nasdaqgmivvd-surges-198-after-positive-results-from","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4535","BK4548","BK4585","IVVD","BNTX","BK4139","BK4588","BK4568","BK4551"],"gpt_icon":1},{"id":"2514339412","title":"Moderna Shares Fall After Reports of HHS Review of Bird Flu Vaccine Contract -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2514339412","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514339412?lang=en_us&edition=fundamental","pubTime":"2025-02-28 03:02","pubTimestamp":1740682920,"startTime":"0","endTime":"0","summary":"Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company's $590 million contract to help develop a bird-flu vaccine.Moderna was awarded the contract from the U.S. Department of Health and Human Services in January during the Biden administration to accelerate development of its mRNA-based vaccine, and as part of an effort to address growing concerns of a bird flu pandemic in humans.The Trump administration is currently reviewing the contract, according to a person familiar with the matter.\"While it is crucial that the U.S. Department and Health and Human Services support pandemic preparedness, four years of the Biden administration's failed oversight have made it necessary to review agreements for vaccine production,\" an HHS spokesman said.A bird-flu outbreak has plagued American farmers, infecting commercial and backyard poultry folks that has contributed to sky-high egg prices and dozens of people getting sick.Vaxart, anothe","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4009","BK4585","BK4588","BK4532","BK4501","BK4534","MRNA","BK4533","BK4568","BK4548","HHS","BK4139","BK4551"],"gpt_icon":1}],"pageSize":16,"totalPage":19,"pageCount":14,"totalSize":301}]}}